RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
This Quarter Return
-5.34%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.57B
AUM Growth
+$1.57B
(-11%)
Cap. Flow
-$46.7M
Cap. Flow
% of AUM
-2.96%
Top 10 Holdings %
Top 10 Hldgs %
25.73%
Holding
273
New
11
Increased
56
Reduced
164
Closed
13
Top Buys
| 1 |
TKO Group
TKO
|
$37.8M |
| 2 |
Establishment Labs
ESTA
|
$5.27M |
| 3 |
Aspen Aerogels
ASPN
|
$4.25M |
| 4 |
Evolus
EOLS
|
$3.86M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$3.63M |
Top Sells
| 1 |
WWE
World Wrestling Entertainment
WWE
|
$51.6M |
| 2 |
Qualys
QLYS
|
$8.46M |
| 3 |
CSW
CSW Industrials, Inc.
CSW
|
$8.4M |
| 4 |
LCI Industries
LCII
|
$6.71M |
| 5 |
MSC Industrial Direct
MSM
|
$5.66M |
Sector Composition
| 1 | Healthcare | 27.91% |
| 2 | Technology | 24.61% |
| 3 | Industrials | 19.75% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Communication Services | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
FMC
FMC
$4.63B
| $751K | 0.05% |
11,216
| – | – |
|
227
IDEX
IEX
$12.1B
| $738K | 0.05% |
3,546
| – | – |
|
228
AbbVie
ABBV
$374B
| $721K | 0.05% |
4,836
-50
| -1% | -$7.45K |
|
229
Travere Therapeutics
TVTX
$1.75B
| $701K | 0.04% |
78,362
-1,481
| -2% | -$13.2K |
|
|
LTHM
230
DELISTED
Livent Corporation
LTHM
| $675K | 0.04% |
36,679
+1,400
| +4% | +$25.8K |
|
231
Denny's
DENN
$230M
| $661K | 0.04% |
78,005
-1,269
| -2% | -$10.7K |
|
232
CDW
CDW
$21.4B
| $639K | 0.04% |
3,167
-6
| -0.2% | -$1.21K |
|
233
Chevron
CVX
$318B
| $630K | 0.04% |
3,737
| – | – |
|
234
scPharmaceuticals
SCPH
$296M
| $620K | 0.04% |
87,071
+7,241
| +9% | +$51.6K |
|
235
Teledyne Technologies
TDY
$25.5B
| $592K | 0.04% |
1,450
-3
| -0.2% | -$1.23K |
|
236
Crane NXT
CXT
$3.49B
| $540K | 0.03% |
9,710
-17
| -0.2% | -$945 |
|
237
Berkshire Hathaway Class A
BRK.A
$1.08T
| $531K | 0.03% |
1
| – | – |
|
238
Abbott
ABT
$230B
| $497K | 0.03% |
5,136
-150
| -3% | -$14.5K |
|
239
Y-mAbs Therapeutics
YMAB
$390M
| $497K | 0.03% |
91,249
-1,773
| -2% | -$9.66K |
|
240
Jacobs Solutions
J
$17.1B
| $484K | 0.03% |
4,286
| – | – |
|
241
Apple
AAPL
$3.54T
| $479K | 0.03% |
2,800
| – | – |
|
242
Glacier Bancorp
GBCI
$5.79B
| $474K | 0.03% |
16,645
-26
| -0.2% | -$741 |
|
243
Inotiv
NOTV
$54.3M
| $468K | 0.03% |
151,990
-2,989
| -2% | -$9.21K |
|
244
iShares Russell 2000 Growth ETF
IWO
$12.3B
| $458K | 0.03% |
2,043
+1,151
| +129% | +$258K |
|
245
Exxon Mobil
XOM
$477B
| $429K | 0.03% |
3,650
| – | – |
|
|
VRNA
246
Verona Pharma
VRNA
$9.18B
| $422K | 0.03% |
+25,874
| New | +$422K |
|
247
Sysco
SYY
$38.8B
| $367K | 0.02% |
5,552
| – | – |
|
248
Scholar Rock
SRRK
$3.3B
| $336K | 0.02% |
47,373
-449
| -0.9% | -$3.19K |
|
249
Columbia Sportswear
COLM
$3.1B
| $306K | 0.02% |
4,125
| – | – |
|
250
Procter & Gamble
PG
$370B
| $300K | 0.02% |
2,059
| – | – |
|